It has been recognized for many years that patients who achieve a high workload on exercise stress testing have an excellent prognosis, particularly in the absence of ischemic ST segment depression. [1] [2] [3] [4] Outpatients with a low-risk Duke Treadmill Score (based on exercise duration, magnitude of ST deflection and an angina index) had an observed annual mortality rate of only 0.25%. 5 Exercise capacity has been shown to be a better predictor of all-cause mortality than maximum exercise heart rate.
It has been recognized for many years that patients who achieve a high workload on exercise stress testing have an excellent prognosis, particularly in the absence of ischemic ST segment depression. [1] [2] [3] [4] Outpatients with a low-risk Duke Treadmill Score (based on exercise duration, magnitude of ST deflection and an angina index) had an observed annual mortality rate of only 0.25%. 5 Exercise capacity has been shown to be a better predictor of all-cause mortality than maximum exercise heart rate. 1 Myers et al 1 reported that patients achieving a workload of C10 metabolic equivalents (METs), even in the presence of cardiovascular disease, had a relatively low risk of death during follow-up. For every 1-MET increment in peak treadmill workload, there was an associated 12% improvement in survival. These investigators found that, in both healthy subjects and those with cardiovascular disease, the peak exercise capacity was a stronger predictor of an increased risk of death than clinical variables or coronary artery disease (CAD) risk factors such as hypertension, smoking, and diabetes. It had greater prognostic value than peak exercise heart rate, ST depression, or exercise-induced arrhythmias. Morise et al 6 found a 14% reduction in cardiac events among subjects \65 years of age, and an 18% reduction among subjects C65 years of age for each 1-MET increase in workload. After adjustment for age, the peak METs achieved was the strongest predictor of subsequent mortality. In another study, among patients with a positive exercise ECG, who achieved C10 METs, 93% had a negative exercise echocardiogram and less than 1% mortality after 7.2 years of follow-up. 7 More recently, Bourque et al 8 from the University of Virginia reported that in more than 470 consecutive patients referred for exercise SPECT myocardial perfusion imaging (MPI), who achieved C85% of maximum predicted heart rate (MPHR) and C10 METs, the prevalence of significant ischemia defined as comprising 10% or more of the left ventricle (LV), was only 0.4%. In fact, no patient who achieved C10 METs without ischemic ST depression had significant ischemia on MPI. The prevalence of 5-9% LV ischemia in such patients was also very low at 0.7%. This population had an intermediate-to-high pretest likelihood of CAD, with 20% having known CAD and 70% with chest pain as the indication for testing. Ischemia involving C10% of the LV was also low (2.4%) in the 82 patients who achieved C10 METs, but \85% of MPHR. Bourque et al 9 then published the subsequent cardiac mortality and nonfatal cardiac event rates in this patient cohort achieving C10 METs. They reported a remarkably low annual cardiac mortality of 0.1% and a combined annual cardiac death or nonfatal myocardial infarction rate of 0.4%. None of the event patients had either [5% or [10% LV ischemia, and none was in the subsets which achieved \85% of MPHR or who had ST depression. Therefore, even if perfusion imaging was performed, it would not have identified the patients who subsequently had events. Interestingly, the annual cardiac death or nonfatal infarction rate was lower in patients who achieved C10 METs than observed in patients with normal stress perfusion scans regardless of workload achieved. These studies by Bourque et al, 8, 9 together with prior published reports relating the excellent prognosis in patients achieving high exercise workloads, bring into question the added prognostic value, and cost-effectiveness of MPI or stress echo in patients achieving C10 METs and no ischemic ST depression, regardless of the exercise heart rate and whether they have a history of prior CAD.
In this issue of the journal, Duvall et al, 10 recognizing that the results of MPI seemed to add little to risk assessment of patients who exercise to 10 METs or more during stress testing, seek to determine if a provisional tracer injection protocol could be developed in which a patient would not have the tracer administered intravenously if C10 METs was achieved without symptoms and with a negative stress ECG response. They retrospectively reviewed all patients who underwent a SPECT MPI study over a 6.5-year period and estimated how many patients might have been eligible for a ''standby injection'' protocol with provisional MPI. The criteria they employed for identifying this noninjection group included no known CAD, \65 years of age, an interpretable rest ECG, attaining C85% of MPH, achieving C10 METs with no symptoms of chest pain or significant dyspnea, and manifesting no ischemic ST depression or exercise-induced arrhythmias. They determined that 6.3% of their total cohort of approximately 25,000 patients who underwent SPECT MPI during this survey period fulfilled these criteria and would not have been injected with a tracer for MPI. Abnormal perfusion on MPI was seen in 5.9% of the hypothetical noninjection group, with only 1.3% having a stress perfusion defect of [10%. At approximately 5 years of follow-up, all cause mortality was just 1.1% in those patients who would not have been injected with tracer. Interestingly, of the approximate 5,300 patients in this cohort eligible for the provisional imaging protocol before testing because they were referred for exercise testing, were\65 years of age with no known CAD, and had an interpretable baseline ECG, only 29% would not have been injected because of failure to fulfill all criteria described above.
The number of patients who might not have been injected with tracer for MPI could have been expanded if Duvall et al 10 did not include shortness of breath as an endpoint or included patients with an intermediate pretest likelihood of CAD who were [65 years of age. Patients were withdrawn from the provisional imaging protocol if they had right bundle branch block on their resting ECG. Such patients do have interpretable ST segment changes during testing. Also, dyspnea in patients achieving high workloads with no ST depression should not necessarily eliminate them from eligibility for a noninjection protocol. Bourque et al 9 found an excellent prognosis in patients achieving C10 METs but less than 85% of MPHR. Such patients who do not exhibit ST depression or limiting angina might also be eligible for a noninjection protocol. Outcome data regarding patients who were [65 years of age, had dyspnea as an endpoint, or had C10 METs but \85% of MPHR are not provided. Further clinical research appears warranted to determine if such patients also have a low prevalence of ischemia by MPI and a good prognosis. This would expand the pool of patients referred for exercise stress testing for which MPI might not add additional prognostic information to achieving C10 METs without ST depression.
There are several challenges that would be faced by nuclear cardiology laboratories in implementing such a provisional use of MPI with exercise testing. First, referral physicians and payers would have to agree beforehand that a noninjection protocol would be applied to their patients if they were eligible based on whatever predetermined criteria that were established. Second, insurance companies and Medicare would have to create a new code to cover the cost of an IV, supplies, and unused radioisotope, balanced against the reduced technical and professional charges for the stress test vs an MPI. Third, patients themselves would need to be reassured that not performing MPI would result in an adequate diagnosis of their symptoms and valid risk assessment. A fourth issue is who would decide if tracer should be administered, as in many practice settings, a registered nurse or an exercise physiologist performs the stress test with a physician supervising but not actually present. These are logistics that need to be worked out.
Some referring physicians may not agree with stress-testing personnel, not familiar with the patient's specific circumstances, deciding on the optimal study. Each patient is unique, and the studies referenced above refer to population and not patient-specific outcomes. In daily practice, one sometimes encounters patients with very concerning but not frequently occurring symptoms. One example is a patient who jogged several times a week, usually without symptoms, but who requested assessment because sometimes during jogging, he became suddenly dyspneic and light-headed and felt a sense of doom. During his MPI, he achieved 10.1 METs without chest pain or ST changes, but the images revealed a large area of hypoperfusion anteriorly and apically (see figure, courtesy of Dr Iain McGhie of Saint-Lukes Cardiovascular Consultants). Coronary angiography showed a high-grade proximal LAD stenosis. His coronary artery calcium score was 3.
Given the logistic, economic, billing, and potentially legal (can a lab substitute an ordered test for another without specific authorization from the referring physician?) issues associated with a provisional imaging strategy, perhaps providers should also consider whether the pendulum has swung too far in favor of stress imaging as an initial test. For example, most patients with normal resting ECGs who might have the capability to achieve C10 METs might best be triaged initially to nonimaging exercise stress testing. The Duke Activity Status Index (DASI) is a simple self-administered 12-item questionnaire that predicts METs likely to be achieved on exercise treadmill testing. 11 Being able to predict beforehand which patients are most likely to achieve high workloads would reduce the number of radioisotope doses prepared for provisional imaging. The ''What Is the Optimal Method for Ischemia Evaluation in Women?'' (WOMEN) trial used the DASI to identify women with suspected CAD, an interpretable ECG, and C5 METs who were randomized to standard initial exercise ECG testing or to exercise MPI.
12 At 2 years, there was no difference in major adverse cardiac events between the two groups. A strategy of initial exercise ECG testing yielded similar outcomes vs exercise MPI while providing significant diagnostic cost savings. Thus, this is one example where a pretest evaluation of functional capacity was used to identify a low-risk subgroup of exercising women who do not appear to benefit from initial as opposed to adjunctive MPI. Their survival free score of CAD death or hospitalization for an acute coronary syndrome or heart failure was 98.8% at 2 years. Another option is stressfirst/stress-only imaging if the stress image is normal. 13, 14 Optimally, given the low-risk of the population under consideration, this would be performed using one of the newer cameras that permit very low tracer dosages.
One approach for patient and referral physician reassurance that elimination of MPI would not miss patients with significant CAD, is to have patients who achieve C10 METs with no ST depression, and not injected with tracer, but are still at intermediate risk based for CAD based on the type of chest pain experienced and having multiple risk factors for CAD including diabetes, undergo CT coronary calcium imaging (CAC). 15 Those exhibiting limiting dyspnea as .
an exercise endpoint, and perhaps those aged 65-70 years might also benefit from CT CAC if they achieve a high workload with no ST depression. This would permit the detection of coronary atherosclerosis and lead to more aggressive medical therapy than might otherwise be undertaken after the negative ECG stress test. In addition, for patients with high CAC scores (e.g., [300), a repeat stress test with MPI could be performed for further refining risk. Note, however, that in the patient example described above, the CT CAC score was only 3. In the challenge of test selection, there must always be weight placed on clinical acumen. This is perhaps the greatest drawback of a protocol having laboratory personnel making a decision of substituting one test for another without intimate knowlegde of a patient's unique circumstances. It should be pointed out that the most current update of the stable angina guidelines 16 indicate that standard exercise ECG testing is recommended for patients with an intermediate pretest probability of ischemic heart disease, who have an interpretable ECG and at least moderate physical functioning, or no disabling comorbidity. This is a Class 1 recommendation. It is further stated (as a Class IIa recommendation) that exercise MPI is ''reasonable'' for patients with an intermediateto-high pretest probability of obstructive ischemic heart disease who have an interpretable ECG and at least moderate physical conditioning. Based on the data regarding the very low prevalence of significant ischemia and excellent prognosis for patients achieving C10 METs without ischemic ST depression, the provisional injection protocol, with perhaps some expansion of criteria for eligibility, warrants further consideration and prospective evaluation. This approach might best identify which patients do not require MPI at the outset for evaluation of symptoms suggestive of CAD. The addition of CT CAC imaging in the clinically higher risk patients with negative exercise ECG stress tests at high workloads also warrants a prospective clinical trial to determine its value. Certainly, a nonimaging exercise ECG stress test could be performed alone as the first test in patients prospectively identified as having good functional capacity and deemed at low or low-intermediate pre-test probability for CAD.
